Refine Your Results

Click below to filter your search results

"Guidelines"Undo

Search Results

Return to List
Results 201–214 of 214
Title Date
201.

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT: Tamoxifen, a nonsteroidal antiestrogen agent, is widely used as adjunctive therapy for women with breast cancer, and it has been approved by the U.S. Food and Drug Administration for adjuvant treatment of breast cancer, treatment of metastatic breast cancer, and reduction in breast cance...

June 2014

PDF Format
202.

Depot Medroxyprogesterone Acetate and Bone Effects

Number 602

(Replaces Committee Opinion Number 415, September 2008)

ABSTRACT: Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive that affords privacy and has a convenient dose schedule of four times per year, making it appealing to many users, especially adolescents. Although the use of DMPA is associated with loss of bone mine...

June 2014

PDF Format
203.

Evaluation of Uncomplicated Stress Urinary Incontinence in Women Before Surgical Treatment

Number 603

ABSTRACT: Stress urinary incontinence (SUI) is a condition of involuntary loss of urine on effort, physical exertion, sneezing, or coughing that is often bothersome to the patient and frequently affects quality of life. When women are evaluated for SUI, counseling about treatment should begin with...

June 2014

PDF Format
204.

OnabotulinumtoxinA and the Bladder

Number 604

ABSTRACT: In January 2013, the U.S. Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatment option for women. Symptoms of overactive bladder have been shown to significantly improve after ...

June 2014

PDF Format
205.

Primary Ovarian Insufficiency in Adolescents and Young Women

Number 605

ABSTRACT: Primary ovarian insufficiency is the depletion or dysfunction of ovarian follicles with cessation of menses before age 40 years. There is no consensus on criteria to identify primary ovarian insufficiency in adolescents, and delay in diagnosis is common. Health care providers who make th...

July 2014

PDF Format
206.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Number 606

ABSTRACT: Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding, and gynecologists may be consulted either before the initiation of cancer treatment to request strategies for menstrual suppression or during an episode of severe heavy bleeding to stop the bleeding eme...

August 2014

PDF Format
207.

Gynecologic Concerns in Children and Adolescents With Cancer

Number 607

ABSTRACT: Advancements in radiation therapy, chemotherapy, surgery, and multimodal treatment have dramatically improved childhood cancer survival. However, cancer and its treatment may have immediate or delayed adverse effects on reproductive health. Gynecologists should be prepared to manage gyne...

August 2014

PDF Format
208.

Influenza Vaccination During Pregnancy

Number 608

(Replaces No. 468, October 2010)

ABSTRACT: The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend that all adults receive an annual influenza vaccine. Influenza vaccination is an essential element of preconception, prenata...

September 2014

PDF Format
209.

Colorectal Cancer Screening Strategies

Number 609

ABSTRACT: Each year, more than 24,000 women die from colorectal cancer, which makes it the third leading cause of cancer death in women after lung cancer and breast cancer. However, screening tests are underused for many segments of the population and are ordered in a manner inconsistent with guid...

October 2014

PDF Format
210.

Chronic Antithrombotic Therapy and Gynecologic Surgery

Number 610

ABSTRACT: Surgery can present a management dilemma for gynecologists whose patients receive chronic antithrombotic therapy because the risk of hemorrhagic complications must be balanced against the risk of thromboembolic complications. Interruption of antithrombotic therapy to reduce perioperative...

October 2014

PDF Format
211.

Method for Estimating Due Date

Number 611

(See also Committee Opinion No. 579)

ABSTRACT: Accurate dating of pregnancy is important to improve outcomes and is a research and public health imperative. As soon as data from the last menstrual period, the first accurate ultrasound examination, or both are obtained, the gestational age and the estimated due date should be determin...

October 2014

PDF Format
212.

Abortion Training and Education

Number 612

(Replaces No. 424, January 2009)

ABSTRACT: Access to safe abortion hinges upon the availability of trained abortion providers. The American College of Obstetricians and Gynecologists supports education for students in health care fields as well as clinical training for residents and advanced practice clinicians in abortion care i...

November 2014

PDF Format
213.

Increasing Access to Abortion

Number 613

(Replaces No. 424, January 2009)

ABSTRACT: Safe, legal abortion is a necessary component of women’s health care. The American College of Obstetricians and Gynecologists supports the availability of high-quality reproductive health services for all women and is committed to improving access to abortion. Access to abortion is threa...

November 2014

PDF Format
214.

Management of Pregnant Women With Presumptive Exposure to Listeria monocytogenes

Number 614

ABSTRACT: Listeriosis is predominantly a foodborne illness, with sporadic and outbreak-related cases tied to consumption of food contaminated with listeria (Listeria monocytogenes). The incidence of listeriosis associated with pregnancy is approximately 13 times higher than in the general populati...

December 2014

PDF Format